featured
Obinutuzumab vs Rituximab in Young Patients With Advanced Diffuse Large B-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Obinutuzumab Versus Rituximab in Young Patients With Advanced DLBCL, a PET-Guided and Randomized Phase 3 Study by LYSA
Blood 2020 Nov 19;[EPub Ahead of Print], S Le Gouill, H Ghesquieres, L Obéric, F Morschhauser, H Tilly, V Ribrag, T Lamy, C Thieblemont, HG Maisonneuve, R Gressin, K Bouabdallah, C Haioun, G Damaj, LM Fornecker, R Bouabdallah, P Feugier, D Sibon, G Cartron, C Bonnet, M André, L Chartier, P Ruminy, F Kraeber-Bodere, C Bodet-Milin, A Berriolo-Riedinger, J Briere, JP Jais, T Molina, E Itti, O CasasnovasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.